Dimethylarginine dimethylaminohydrolase (DDAH) degrades asymmetric dimethylarginine (ADMA), an endogenously produced nitric oxide (NO) synthase inhibitor. In mammals, two isoforms of DDAH, DDAH1 and DDAH2, are expressed in the cardiovascular system, suggesting that ADMA concentrations are actively regulated in blood vessels, raising the possibility that cardiovascular metabolism of ADMA constitutes a novel mechanism for the regulation of NO production. The purpose of this study was to determine the role of DDAH-catalyzed asymmetric methylarginine metabolism in the regulation of vascular function. We developed adenoviral vectors for the expression of human DDAH1 and 2. Overexpression of DDAH1 or 2 in human umbilical vein endothelial cells (HUVEC) increases DDAH activity, reduces ADMA concentrations and increases NO production. Similarly, overexpression of DDAH1 or 2 in DDAH1 +/mice carotid vessels increases NO production and attenuates the response to phenylephrine (PE), enhances acetylcholine (ACh) relaxation and attenuates the effect of exogenously applied ADMA. Finally, overexpression of either DDAH1 or 2 completely reversed the vascular dysfunction seen in DDAH1 +/mice. These data indicate that basal concentrations of ADMA in blood vessels are sufficient to regulate NO production, that increases in the level of either DDAH1 or 2, improves vascular function and that overexpression of either DDAH1 or 2 is sufficient to compensate for life-long exposure to elevated ADMA. Thus, therapeutic manipulation of DDAH expression or activity may represent a novel approach to improve vascular dysfunction in various cardiovascular diseases.
Introduction
Nitric oxide (NO) is a key physiological mediator in the cardiovascular, neuronal and immune systems. Numerous reports have detailed the effects of reduced NO production on signaling in these systems and reduced NO generation has been associated with many pathological conditions. 1 In the cardiovascular system, genetic or pharmacological inhibition of NO production leads to attenuation of vascular relaxation, increased vascular resistance and increased blood pressure. Therefore, endogenous mechanisms that regulate NO production are of considerable interest. 2 In the cardiovascular system, NO is synthesized by the endothelial isoform of nitric oxide synthase (eNOS) and the activity of this enzyme has been reported to be regulated at many levels including transcription, translation, post-translational modification and co-factor availability. 2 In addition to these mechanisms, eNOS activity can be regulated by the level of endogenously produced asymmetrically methylated arginines which are competitive enzyme inhibitors. 3 In humans, two endogenously produced asymmetric methylarginines are present; asymmetric dimethylarginine (ADMA) and N-monomethylarginine (l-NMMA). However, ADMA is found at approximately 10-fold the concentration of l-NMMA and is therefore thought to be the most functionally significant asymmetric methylarginine. 3 Methylarginines are generated by the post-translational methylation of certain arginine residues in proteins catalyzed by a family of protein arginine methyltransferases (PRMTs). 4, 5 Proteolysis of arginine methylated proteins leads to the liberation of free methylarginines which have the potential to compete with arginine at the active site of NOS and thereby inhibit enzyme activity. An increasing volume of literature documents the association between raised plasma ADMA concentrations and a range of cardiovascular disease states. 3, [6] [7] [8] In some of these reports decreased NO production has been implicated in disease pathology and it has been suggested that inhibition of eNOS activity by ADMA is a mechanism of disease. However, until recently, direct evidence confirming this causal relationship between ADMA and NO in vivo has been lacking.
In addition to endogenous production, asymmetric methylarginines are also metabolized in vivo. The enzyme dimethylarginine dimethylaminohydrolase (DDAH) hydrolyses both ADMA and l-NMMA to citrulline and di-or mono-methylamine respectively. In humans, two isoforms of DDAH (DDAH1 and 2) are found with distinct but overlapping tissue distributions. 9 In the cardiovascular system both DDAH1 and 2 are expressed in both endothelial and smooth muscle cells, suggesting that in blood vessels asymmetric methylarginine concentrations are actively regulated and that this pathway constitutes a novel mechanism for the regulation of NO and vascular function.
Consistent with this suggestion, global heterozygous deletion of DDAH1 in mice attenuates vascular NO signaling resulting in endothelial dysfunction and increased systemic vascular resistance and blood pressure in vivo. 10 Conversely, global overexpression of DDAH1 in mice increases the concentration of nitrogen oxides (NOx) in the plasma and is associated with reduced systolic blood pressure. 11 In transgenic mice globally overexpressing DDAH2, increased cardiac NOx was apparent; however, no change in systolic blood pressure was observed. 12 However, the role of DDAH in the regulation of vascular NO signaling has only been studied in DDAH1 transgenic mice 13 and therefore the precise roles of DDAH1 and 2 remain unclear.
In the present study, we aimed to study the effect of DDAH catalyzed asymmetric methylarginine metabolism in blood vessels. We developed adenoviral vectors for the expression of human DDAH1 and 2 in vascular cells and tissues. Overexpression of DDAH1 or 2 in HUVECs increased DDAH activity, reduced ADMA concentrations and increased NO production. Similarly, adenoviralmediated overexpression of DDAH1 or 2 in mice carotid vessels increased NO production in static culture. When carotid vessels were studied using myography, overexpression of DDAH1 or 2 attenuated the response to phenylephrine (PE), enhanced acetylcholine (ACh) relaxation and attenuated the effect of exogenously applied ADMA. Finally, overexpression of either DDAH1 or 2 completely reversed the vascular dysfunction seen in DDAH1 +/mice. These data indicate that (1) basal concentrations of ADMA in blood vessels are sufficient to regulate NO production; (2) increases in the level of either DDAH1 or 2 improves vascular function; and (3) overexpression of either DDAH1 or 2 is sufficient to compensate for DDAH1 haploinsufficiency.
Methods

Construction of recombinant adenovirus
Recombinant DDAH1 and DDAH2 adenoviruses (AdDDAH1 and AdDDAH2) were generated using the protocol from Stratagene AdEasy System (http://www.coloncancer.org/ adeasy/protocol2.htm). 14 Adenoviral vectors expressing green fluorescent protein (AdGFP) were used as controls.
Cell culture
HUVECs and all cell culture reagents were purchased from PROMOCELL and cultured as described previously 15 and used prior to passage 6. HUVECs were grown in six-well plates until confluent and infected with adenoviruses at an MOI that we have previously determined to result in optimal infection (MOI = 1000) in medium containing 2% fetal calf serum (FCS) for 1 h, following which the medium was replaced with Phenol Red-free culture medium containing 10% FCS. The media was collected for nitrite and ADMA determination 24 h after infection and the cells processed for fluorescence microscopy or western blotting.
Nitrite determination
To measure nitrite, a stable end product of NO degradation, an aliquot of medium (100 µl) from each culture well was mixed with 100 µl of the Griess reagent (1% sulfanilamide and 0.1% naphthylenediamine dihydrochloride in 2% phosphoric acid). The mixture was incubated for 10 min at room temperature to allow the color to develop, and the absorbance at 540 nm was measured in a microplate reader. Concentrations were determined by comparison with a sodium nitrite standard curve.
ADMA/SDMA measurements
Levels of ADMA and its biologically inactive isomer symmetric dimethylarginine (SDMA) were quantitated by HPLC in conditioned medium as previously described. 10 
Western blotting
Cells or tissues were lysed in cell lysis buffer (125 mM HEPES, pH 7.5, 750 mM NaCl, 5% Igepal CA-630, 50 mM MgCl 2 , 5 mM EDTA and 10% glycerol; Upstate Biotechnology), the protein concentration determined using a Bio-Rad protein assay kit with bovine serum albumin standards. Protein samples (50 µg) were separated on 12% SDS-polyacrilamide gels, transferred to nitrocellulose membranes, and probed with affinity-purified polyclonal antibodies specific for DDAH1 or 2, 14 a-tubulin or GFP. Immunoreactive bands were visualized with a horseradish peroxidase conjugated secondary antibody using an ECL detection kit (Amersham).
DDAH activity assay
HUVECs were grown to confluence in 75 cm 2 flasks and infected as described above. At 24 h post infection, cells were scraped from the flask in ice-cold lysis buffer (sodium phosphate, pH 6.6 (10 mM), containing 0.1% Triton X-100) and incubated on ice for 20 min. Cell debris was removed by centrifugation and supernatants assayed for DDAH activity using a colorimetric assay for the determination of enzymatically formed citrulline as previously described. 16 
Infection of carotid arteries
All the experiments were carried out under a UK Home Office License and conducted according to the Animal Scientific Procedures Act 1986.
Male mice aged 10-12 weeks old (DDAH1 +/or DDAH1 +/+ on C57Bl6 background) were sacrificed with an overdose of isofluorane, carotid arteries exposed by dissection in situ and the distal ends ligated. A mixture of adenovirus and cell culture medium (5 µl of 1 × 10 9 plaqueforming units/ml virus plus 20 ml of Dulbecco's modified Eagle's medium (DMEM) containing 2% FCS) was introduced into the proximal end of each carotid artery (one side with AdDDAH1 or 2 and the contralateral artery with AdGFP), following which the proximal end was ligated. The ligated segment was removed and incubated in tissue culture medium (DMEM containing 10% FCS) for 4 h, after which the ligatures were removed, the vessel cut into four ~4mm segments and then incubated in fresh tissue culture medium for a further 24 h. Following incubation, vessels were either processed for microscopy, mounted in myographs for functional studies, or homogenized for western blotting. Tissue culture medium was collected for nitrite determination.
Fluorescence microscopy
Fluorescence microscopy was used to monitor viral infection of cultured endothelial cells and carotid arteries. For endothelial cells cultures, cells were stained with DAPI to identify nuclei and the transfection efficiency determined. At the MOI used, > 90% infection of endothelial cells was observed and no difference in the transfection efficiency between GFP, GFP-DDAH1 and GFP-DDAH2 viruses was apparent. For analysis of infected arteries, rings were opened and fixed in 4% formaldehyde dissolved in PBS for 15 min and permeabilized for 3 min in 0.1% Triton X-100 (Sigma). F-actin was labeled with 1 µg/ml TRITCphalloidin (Sigma) for 1 h. Single plain images of the cells were obtained by confocal laser scanning microscopy (Bio-Rad Radiance 2100) with Bio-Rad software (LaserSharp 2000 version 5.1). 14 
Determination of carotid arterial vascular reactivity
Carotid arteries from male 10-12-week-old DDAH1 +/and wild-type littermates on a pure C57Bl6 background were used for functional studies. Rings were mounted in myograph (Danish Myotechnology) and bathed in PSS (physiological salt solution; 37°C gassed with 5% CO 2 in O 2 ) at a resting tension determined by the diameter of the vessel. After equilibration, vessels were stimulated with throm-boxane A2 mimetic U-46619 (10 -6 mol/l) until responses were reproducible. The functional integrity of the endothelium was confirmed routinely by the presence of relaxation induced by ACh 10 -6 mol/l during contraction obtained with PE 10 -6 mol/l. For wild-type animals only, arteries which presented more than 60% relaxation were considered as endothelial intact and used for the experiments. However, as we hypothesized that DDAH1 deletion will cause endothelial dysfunction, this value was reduced to 30% for vessels from DDAH1 +/mice. Concentration response curves to PE (10 -8 to 10 -4 mol/l) and ACh (10 -9 to 3 × 10 -6 mol/l) were constructed. In order to study ADMA contraction, vessels were precontracted with an effective concentration of PE to achieve 20% of maximal response (PE EC 20 ) and a cumulative concentration response curve to ADMA (10 -8 to 10 -3 mol/l) was determined. After myography, fluorescence microscopy was used to determine transfection efficiency as described above.
Statistical analysis
Statistical analysis was performed with GraphPad Prism version 3.0. All data are given as mean ± standard error of the mean (SEM). Tests of significance were conducted using Student's t-test for differences between data groups, where p < 0.05 was considered significant. PE contraction in carotid arteries was expressed as absolute tension in grams (g). Relaxation was expressed as a percentage of the PE-induced contraction. The ADMA contractile effect was expressed as a percentage of the maximal response to U46619 (10 -6 mol/l). The concentrations of agonist producing half-maximum effect (EC 50 values) was determined from the individual concentration response curves by nonlinear regression analysis and expressed as negative logM. For comparisons of concentration response curves, twoway ANOVA was used. The n values indicate the number of experiments and animals used.
Results
Infection of human primary endothelial cells
Incubation of HUVEC with viruses expressing GFP or GFP-DDAH1 or 2 resulted in > 90% infection efficiency as judged by GFP fluorescence ( Figure 1A ). No differences in the infection efficiency of GFP, GFP-DDAH1 and GFP-DDAH2 viruses were apparent. At 24 h following infection, cells expressing either GFP alone or GFP-DDAH1 or 2 were lysed and soluble fractions were subjected to western blotting using anti-DDAH1 or 2 and anti-a-tubulin antibodies ( Figure 1B) . In GFP-infected cells, a band corresponding to endogenous DDAH1 and 2 was detectable. Following infection with viruses expressing DDAH1 or 2, increased immunoreactivity was observed confirming overexpression of the proteins.
Aliquots of cell lysates were also assayed for DDAH activity using a colorimetric assay to detect the citrulline reaction product (see 'Methods'). Infection of HUVEC with viruses encoding either DDAH1 or 2 increased DDAH activity compared to cells infected with a virus expressing GFP alone ( Figure 1C ; GFP = 100%, DDAH1 = 140.6 ± 10.1%, DDAH2 = 150.8 ± 8.9%, n = 5, p < 0.05).
Conditioned medium from infected cells was also collected 24 h post infection and analyzed to determine methylarginine and nitrite concentrations. Conditioned medium from cells overexpressing either DDAH1 or 2 had significantly lower concentrations of ADMA compared to cells expressing GFP alone ( Figure 1D ; GFP = 8.11 ± 0.09 ng/ ml, DDAH1 = 6.32 ± 0.04 ng/ml, DDAH2 = 5.71 ± 0.02 ng/ml, n = 8, p < 0.05). Levels of SDMA, which is not a substrate for DDAH, were unchanged (data not shown). The reduction in ADMA elaboration was accompanied by increased accumulation of nitrite, a stable breakdown product of NO ( Figure 1E ; GFP = 1.45 ± 0.23 µmol/l, DDAH1 = 3.71 ± 0.61 µmol/l, DDAH2 = 4.11 ± 1.06 µmol/l, n = 8, p < 0.05).
Infection of murine carotid arteries
Carotid arteries from C57Bl6 mice were incubated with virus in situ and maintained in static culture as described (see 'Methods'). One carotid artery was infected with viruses expressing GFP and the contralateral carotid artery was infected either with GFP-DDAH1 or GFP-DDAH2. At 24 h following incubation, conditioned medium was removed from the vessels for determination of GFP protein levels and nitrite concentrations. Infection of vessels with adenoviruses was verified by GFP fluorescence (Figure 2A) . No difference in the level of GFP protein in vessels infected with either DDAH1 or 2 expressing viruses was apparent, indicating that the infection efficiency of the two viruses was similar ( Figure 2B ). Increased nitrite accumulation in the medium of DDAH1 or 2 infected vessels compared to vessels expressing GFP alone was observed ( Figure 2C ; GFP = 2.94 ± 0.92 µmol/l, DDAH1 = 8.67 ± 1.23 µmol/l, DDAH2 = 6.77 ± 1.39 µmol/l, n = 5, p < 0.05). Infection of vessels with adenoviruses encoding GFP alone did not alter nitrite accumulation compared to uninfected vessels (GFP = 2.94 ± 0.92 µmol/l, control = 2.77 ± 0.89 µmol/l, n = 5, p > 0.05) and there was no significant difference nitrite accumulation between DDAH1 and DDAH2 infected vessels. Infection was confirmed by GFP fluorescence.
For measurement of vascular reactivity, carotid arteries were incubated with viruses in situ, removed and cultured ex vivo ('Methods'). Infection was confirmed by GFP fluorescence; no difference in infection efficiency of the viruses used was apparent (data not shown). Segments were mounted under isometric tension in myographs. Endothelial integrity was confirmed as described and then doseresponse curves to PE, ACh and ADMA were constructed ( Figure 3 and Table 1 ). Initially, we established that viral infection of blood vessels did not alter responses to vasoconstrictors and vasodilators (Figure 4 ). Infection with either DDAH1 or DDAH2 significantly reduced the maximal contraction to PE ( Figure 3A) , increased the maximal relaxation to ACh ( Figure 3B ) and decreased the contractile response to exogenous ADMA ( Figure 3C ) compared to control GFP-infected vessels. Only infection with DDAH1 caused a significant shift in the EC 50 of these agents; however, infection with DDAH2 showed a similar trend that did not reach statistical significance in these experiments ( Table 1 ). 
Infection of carotid arteries from DDAH1 +/mice
In order to determine if the vascular dysfunction previously observed in DDAH1 +/mice could be reversed by adenoviral delivery of either DDAH1 or 2, we studied carotid arteries from DDAH1 +/mice. Initially we confirmed that vascular responses in the carotid arteries from DDAH1 +/mice showed a similar pattern of endothelial dysfunction, increased PE and ADMA contraction and reduced ACh relaxation to that which we had observed in aorta and pulmonary arteries ( Figure 5 ). Infection with either DDAH1 or DDAH2 significantly reduced the maximal contraction to PE ( Figure 6A ), increased the maximal relaxation to ACh ( Figure 6B ) and decreased the contractile response to exogenous ADMA ( Figure 6C ) such that the endothelial dysfunction caused by DDAH1 haploinsufficiency was completely reversed. In contrast to wild-type vessels, infection of DDAH1 +/carotid arteries with either DDAH1 or 2 significantly shifted both the maximal response and the EC 50 values ( Table 1 ).
Discussion
This study has several major findings. Overexpression of either DDAH1 or 2 in human endothelial cells is sufficient to reduce ADMA elaboration and increase basal NO generation. In murine blood vessels, similar effects are observed with increased NO production resulting in enhanced responses to vasodilators and reduced contractile responses. Finally, the profound endothelial dysfunction that results from life-long DDAH1 haploinsufficiency in mice is completely reversed by adenovirus-mediated delivery of either DDAH1 or DDAH2 genes. Taken together these data indicate that in primary vascular cells and tissues, basal ADMA concentrations are sufficient to exert tonic inhibition of eNOS and that DDAH activity is insufficient to maintain ADMA concentrations below an inhibitory threshold. Furthermore, functional redundancy exists between DDAH isoforms with increased expression of either DDAH1 or 2 being sufficient to increase vascular function and reverse the effect of DDAH1 haploinsufficiency. In this study, we first used primary HUVECs as they are known to constitutively express eNOS, DDAH1 and DDAH2 and to release measurable quantities of both ADMA and NO (detected in the medium as nitrite). 15, 17, 18 We chose to overexpress DDAH isoforms using the adenovirus system as this has previously been shown to result in highly efficient infection of vascular cells in culture and tissues ex vivo. In our studies we observed > 90% infection of HUVEC in culture that resulted in high level expression of DDAH isoforms. Despite very substantial overexpression at the protein level we observed a relatively modest increase in total DDAH activity (~30%) that was associated with a similar reduction in ADMA elaboration (~30%). This discrepancy between protein levels and enzymatic activity is also apparent in several other studies where DDAH transfection has been used to modulate ADMA levels 11, 12, 15, 19, 20 and might indicate that either (1) overexpression of DDAH produces predominantly misfolded and inactive protein or (2) that DDAH proteins are subject to post-translation regulation. We have fractionated DDAH proteins produced by overexpression and found them to be soluble proteins residing in the cytosol, suggesting that they are not grossly misfolded and perhaps supporting the notion that DDAH enzymes can be regulated post-translationally.
To determine the effect of DDAH overexpression on NO synthesis we measured the accumulation of nitrite, a stable breakdown product of NO, in the conditioned medium of transfected HUVEC. We observed a very large increase in 24 h nitrite accumulation following transfection with either DDAH1 or 2. These data indicate that basal ADMA is sufficient to exert significant inhibition of eNOS activity in primary human endothelial cells and that relatively modest increases in total DDAH activity and associated reduction in ADMA are sufficient to cause a very substantial increase in endothelial NO production. In our experiments there was no significant difference in nitrite production between DDAH1 and DDAH2 transfected cells indicating that, at least at the level of overexpression, there is functional redundancy between DDAH isoforms in endothelial cells.
To extend our observation of endothelial cells in culture into blood vessels we studied mouse carotid arteries that had been infected with adenoviruses in situ. We determined the efficiency of infection by measuring GFP fluorescence and observed that intraluminal infection of blood vessels resulted in almost exclusively endothelial expression of GFP. Consistent with our observations from cell culture, vascular infection with adenoviruses expressing either DDAH1 or DDAH2 resulted in a large increase in nitrite in the conditioned medium. When we determined the vascular reactivity of infected carotid arteries, consistent with our observation of increased NO production, we observed a significant reduction in the maximal response to PE and a significant increase in the maximal ACh response in vessels overexpressing either DDAH1 or 2 when compared to GFP infected vessels. These observations demonstrate for the first time that in intact blood vessels basal ADMA concentrations regulate eNOS activity and that DDAH activity is insufficient to maintain ADMA concentrations below inhibitory levels. These findings are consistent with studies of genetically modified mice that globally overexpress either DDAH1 or 2. 11, 12 In these mice, substantial overexpression of DDAH resulted in increased DDAH activity (~ threefold for DDAH1 and ~0.5-fold for DDAH2), reduced circulating ADMA (-60% for DDAH1 and -25% for DDAH2), and increased nitrite concentrations in the urine of DDAH1 transgenic mice or in the cardiac tissue of DDAH2 transgenic mice. When cardiovascular function was studied in these mice significant changes were only observed in DDAH1-overexpressing mice, where a significant increase in heart rate and a trend towards lower mean arterial pressure and systemic vascular resistance was observed. In contrast, no difference in systolic blood pressure was observed in DDAH2 overexpressing mice. 11, 12 These differences in hemodynamic phenotype might result from differences in the magnitude of DDAH overexpression. However, the effect of DDAH overexpression on vascular function has only been studied in cerebral vessels from DDAH1 transgenic mice which overexpress DDAH1 in both endothelial and smooth muscle cells. 13 In these vessels, enhanced relaxation in response to ACh was observed; however, it was not possible to determine the relative contribution of endothelial and smooth muscle cell-derived ADMA to this effect. Our data indicate that endothelial overexpression of either DDAH1 or 2 is sufficient to enhance responses to vasodilators and reduce responses to vasoconstrictors in systemic blood vessels, which would lower vascular resistance and blood pressure in vivo.
In our final set of experiments, we determined the ability of the adenovirus-mediated DDAH gene delivery to reverse the endothelial dysfunction seen in DDAH1 +/mice. These mice have life-long exposure to elevated ADMA concentrations that are similar to those seen in many human cardiovascular disease states. Whilst it is clear that raised ADMA causes endothelial dysfunction it is not known whether this phenotype is reversible by acute elevation of DDAH activity. Previously we have demonstrated that endothelial dysfunction in aorta from DDAH1 +/mice could be reversed with high concentrations of exogenous arginine ex vivo. 10 However, recent trials of high-dose arginine supplementation have produced negative results, indicating that this is not a viable mechanism to reverse the effects of ADMA. 21 Our data presented here indicate that adenovirus-mediated delivery of either DDAH1 or DDAH2 is sufficient to substantially reverse the endothelial dysfunction of DDAH1 +/mice. These observations suggest that in human cardiovascular diseases where reduced DDAH activity and increased ADMA play a role in pathology, interventions resulting in increased expression and/or activity of either DDAH1 or 2 may be therapeutically useful. We have previously reported that retinoic acid-induced upregulation of DDAH2 expression in endothelial cells is associated with reduced ADMA elaboration and increased NO production, demonstrating that, in principle, transcriptional upregulation of DDAH can result in beneficial increases in endothelial NO production. 22 Numerous recent studies have indicated that various treatments can regulate DDAH gene expression and that these changes in DDAH level are associated with altered ADMA elaboration and NO synthesis.
Alternatively, post-translational activation of DDAH proteins would achieve the same result. However, to date, no post-translational modifications of DDAH that result in increased activity have been reported. Our observation that following DDAH overexpression there is a poor correlation between DDAH protein level and activity might indicate that post-translational mechanisms exist to modulate DDAH activity. These observations merit further investigation.
It is well established that reduced NO production following surgical procedures such as venous grafting and angioplasty contributes to vascular smooth muscle cell proliferation and restenosis. A number of therapeutic approaches to reduce smooth muscle cell proliferation in these situations, including drug-eluting stents and VEGF gene therapy, have been investigated. 23, 24 It has previously been reported that endothelial cells repopulating injured vessels have higher intracellular ADMA concentrations than would be predicted to attenuate NO production. 25, 26 Our data suggest that local adenovirus-mediated delivery of DDAH genes would be sufficient to reduce endothelial ADMA concentrations and promote NO production in these situations. Several studies have reported that vascular delivery of NOS genes improves endothelial function in models of cardiovascular disease [27] [28] [29] and our current findings indicate that manipulation of DDAH levels could achieve similar results.
